These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19297124)

  • 21. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
    Carey RM; Calhoun DA; Bakris GL; Brook RD; Daugherty SL; Dennison-Himmelfarb CR; Egan BM; Flack JM; Gidding SS; Judd E; Lackland DT; Laffer CL; Newton-Cheh C; Smith SM; Taler SJ; Textor SC; Turan TN; White WB;
    Hypertension; 2018 Nov; 72(5):e53-e90. PubMed ID: 30354828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistant hypertension.
    Viera AJ
    J Am Board Fam Med; 2012; 25(4):487-95. PubMed ID: 22773717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistant hypertension: identifying causes and optimizing treatment regimens.
    Trewet CL; Ernst ME
    South Med J; 2008 Feb; 101(2):166-73. PubMed ID: 18364619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistant hypertension: a review of diagnosis and management.
    Vongpatanasin W
    JAMA; 2014 Jun; 311(21):2216-24. PubMed ID: 24893089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of difficult-to-control hypertension.
    Graves JW
    Mayo Clin Proc; 2000 Mar; 75(3):278-84. PubMed ID: 10725955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistant hypertension: an overview.
    Pedrinelli R; Dell'omo G; Cameli M; Cerbai E; Coiro S; Emdin M; Liga R; Marcucci R; Morrone D; Palazzuoli A; Savino K; Padeletti L; Ambrosio G;
    Minerva Cardioangiol; 2018 Jun; 66(3):337-348. PubMed ID: 28880055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current options for the treatment of resistant hypertension.
    Ahmed MI; Pisoni R; Calhoun DA
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1385-93. PubMed ID: 19900021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.
    Pedrosa RP; Drager LF; Gonzaga CC; Sousa MG; de Paula LK; Amaro AC; Amodeo C; Bortolotto LA; Krieger EM; Bradley TD; Lorenzi-Filho G
    Hypertension; 2011 Nov; 58(5):811-7. PubMed ID: 21968750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment resistant hypertension.
    Bolli P
    Am J Ther; 2008; 15(4):351-5. PubMed ID: 18645339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension Update: Resistant Hypertension.
    Viera AJ
    FP Essent; 2018 Jun; 469():20-25. PubMed ID: 29863319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.
    van Jaarsveld BC; Krijnen P; Derkx FH; Deinum J; Woittiez AJ; Postma CT; Schalekamp MA
    J Hum Hypertens; 2001 Oct; 15(10):669-76. PubMed ID: 11607795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approach to cases with resistant hypertension.
    Torun D
    Anadolu Kardiyol Derg; 2014 Mar; 14(2):192-5. PubMed ID: 24566515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and treatment of resistant hypertension.
    Pisoni R; Ahmed MI; Calhoun DA
    Curr Cardiol Rep; 2009 Nov; 11(6):407-13. PubMed ID: 19863864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistant Hypertension Updated Guidelines.
    Chernova I; Krishnan N
    Curr Cardiol Rep; 2019 Aug; 21(10):117. PubMed ID: 31471727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What is resistant hypertension and how to diagnose it?].
    Lorthioir A; Belmihoub I; Amar L; Azizi M
    Rev Prat; 2019 Dec; 69(10):1099-1103. PubMed ID: 32237581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory blood pressure and adherence monitoring: diagnosing pseudoresistant hypertension.
    Burnier M; Wuerzner G
    Semin Nephrol; 2014; 34(5):498-505. PubMed ID: 25416658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.